Researcher wins funding toward treating multiple myeloma

Julie O'Neal
O’Neal

Multiple myeloma is an incurable malignancy of mature plasma cells. Julie O’Neal, assistant professor of medicine at the School of Medicine, received a $250,000 award from the International Myeloma Society. The award will be used to develop novel immunotherapy treatments for multiple myeloma, a common blood cancer.  

Leave a Comment

Comments and respectful dialogue are encouraged, but content will be moderated. Please, no personal attacks, obscenity or profanity, selling of commercial products, or endorsements of political candidates or positions. We reserve the right to remove any inappropriate comments. We also cannot address individual medical concerns or provide medical advice in this forum.